Fig. 2

Baicalin inhibits the replication of MDV in CEF. a The expression levels of Meq and gB genes in RB-1B strain of MDV infected CEF were quantified by qRT-PCR after treatment with 0, 2 and 20 μg/mL baicalin. b The result of plaque count of RB-1B infected CEF treated with 0, 2 and 20 μg/mL of baicalin. c Inhibitory effects of plaque formation of MDV RB-1B in CEFs by indirect immunofluorescence assays. d The viral encoded gB protein levels were measured by immunoblotting at 96 h p.i. post baicalin treatment. The α-tubulin was used as loading control. The full-length blots are presented in Supplementary Figure 1. Data were expressed as mean ± SD from three independent experiments and analyzed by Student’s t-tests (*** p < 0.001)